Traditional chinese medicine formulation (DrugBank: -)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
85 | 特発性間質性肺炎 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03711435 (ClinicalTrials.gov) | October 20, 2018 | 7/10/2018 | Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics | Study on TCM Syndrome Classification of Idiopathic Pulmonary Fibrosis Based on Metabolomics | Idiopathic Pulmonary Fibrosis | Diagnostic Test: Metabolomics;Drug: Traditional Chinese Medicine Formulation | Xuzhou Traditional Chinese Medicine Hospital | NULL | Completed | 50 Years | 85 Years | All | 60 | China |